Hoth Therapeutics

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell HOTH and other ETFs, options, and stocks.

About HOTH

Hoth Therapeutics, Inc. engages in the development of new generation therapies for dermatological disorders. Its product pipeline focuses on potential treatments for indications including atopic dermatitis (also known as eczema), chronic wounds, psoriasis, asthma, and acne. 

CEO
Robbie Knie
CEORobbie Knie
Employees
6
Employees6
Headquarters
New York, New York
HeadquartersNew York, New York
Founded
2017
Founded2017
Employees
6
Employees6

HOTH Key Statistics

Market cap
15.75M
Market cap15.75M
Price-Earnings ratio
-0.95
Price-Earnings ratio-0.95
Dividend yield
Dividend yield
Average volume
140.32K
Average volume140.32K
High today
$1.04
High today$1.04
Low today
$1.00
Low today$1.00
Open price
$1.04
Open price$1.04
Volume
220.66K
Volume220.66K
52 Week high
$3.80
52 Week high$3.80
52 Week low
$0.6554
52 Week low$0.6554

Stock Snapshot

The current Hoth Therapeutics(HOTH) stock price is $1.01, with a market capitalization of 15.75M. The stock trades at a price-to-earnings (P/E) ratio of -0.95.

On 2025-12-28, Hoth Therapeutics(HOTH) stock traded between a low of $1.00 and a high of $1.04. Shares are currently priced at $1.01, which is +1.0% above the low and -2.9% below the high.

The Hoth Therapeutics(HOTH)'s current trading volume is 220.66K, compared to an average daily volume of 140.32K.

During the past year, Hoth Therapeutics(HOTH) stock moved between $0.66 at its lowest and $3.80 at its peak.

During the past year, Hoth Therapeutics(HOTH) stock moved between $0.66 at its lowest and $3.80 at its peak.

People also own

Based on the portfolios of people who own HOTH. This list is generated using Robinhood data, and it’s not a recommendation.
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer.